Northwestern University researchers are using artificial intelligence (AI) to speed up the search for COVID-19 treatments and vaccines. The AI-powered tool makes it possible to prioritize resources for the most promising ...
May 4, 2020
0
258
Most breast cancers utilize the female hormone estrogen to grow, so drug-induced estrogen deprivation is used as a treatment in many patients. However, cancer will recur in one-third of these patients. A research team at ...
Apr 22, 2020
0
0
A team of Chinese scientists has recently developed two novel compounds that inhibit the SARS-CoV-2 main protease (Mpro) and one of them is a good drug candidate for further clinical studies.
Apr 22, 2020
0
195
The curve of the COVID-19 epidemic has been flattened in many countries around the world, and it hasn't been new antivirals or a vaccine that has done it. We are being saved by non-drug interventions such as quarantine, social ...
Apr 21, 2020
0
1
Drug resistance is a major obstacle in cancer treatment—leading to relapse for many patients. In a new study, published online April 20, 2020, in Nature Cell Biology, researchers from the Stowers Institute for Medical Research, ...
Apr 21, 2020
0
174
A drug that is well-tolerated in patients and prevents cancer coming back in mice has been identified by researchers at the Francis Crick Institute.
Apr 14, 2020
0
368
UC Davis Health researchers have developed a computer model to screen drugs for unintended cardiac side effects, especially arrhythmia risk.
Apr 11, 2020
0
98
Before they were banned about a half century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders. In a commentary publishing April 2 in ...
Apr 2, 2020
0
503
Leiden researchers have developed an app that doctors can use to more easily determine the right dosage of medication for coronavirus patients. At the moment, doctors are prescribing many existing kinds of medication to patients. ...
Mar 26, 2020
0
1
Findings from a phase 2 clinical trial show that the drug selumetinib improves outcomes for children with the genetic disorder neurofibromatosis type 1 (NF1). In the trial, selumetinib shrank the inoperable tumors that develop ...
Mar 18, 2020
0
4
